Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins

Genes and Development

Volumn 8, Issue 6, 1994, Pages 666-677

  White, Alicia E ^a   Livanos, Elizabeth M ^a   Tlsty, Thea D ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

cell cycle control; gene amplification; Genomic instability; HPV 16; p53; pRb

Indexed keywords

ONCOPROTEIN; PROTEIN P53; SPARFOSIC ACID; VIRUS PROTEIN;

ARTICLE; CELL CYCLE; CELL DEATH; CELL STRUCTURE; CELL TRANSFORMATION; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DRUG RESISTANCE; FIBROBLAST; GENE AMPLIFICATION; GENETIC STABILITY; HUMAN; HUMAN CELL; KARYOTYPE; NONHUMAN; POLYPLOIDY; PRIORITY JOURNAL; TUMOR GROWTH; WART VIRUS;

EID: 0028331229     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.8.6.666     Document Type: Article

References (53)

1. Aurias, A. 1993. Acquired chromosomal aberrations in normal individuals. In The causes and consequences of chromosomal aberrations (ed. I.R. Kirsch), pp.125-139. CRC Press, Inc., Ann Arbor, MI.
2. Baker, C.C., W.C. Phelps, V. Lindgren, M.J. Braun, M.A. Gondas, and P.M. Howley. 1987. Structural and translational analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J. Virol 61: 962-971.
3. Barbosa, M.S., C. Edmonds, C. Fisher, J.T. Schiller, D.R. Lowy, and K.H. Vousden. 1990. The region of the HPV E7 oncoprotein homologous to adenovirus E1a and SV40 large T antigen contains separate domains for Rb binding and casein kinase II. EMBO J. 9: 153-160.
4. Crook, T., J.A. Tidy, and K.H. Vousden. 1991. Degradation of p53 can be targeted by HPV E6 sequences distnict from those required for p53 binding and trans-activation. Cell 67: 547-556.
5. Davies, R., R. Hicks, T. Crook, J. Morris, and K. Vousden. 1993. Human papillomavirus type 16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation. J. Virol. 67: 2521-2528.
6. Debbas, M. and E. White. 1993. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes & Dev. 7: 546-554.
7. Dhanwada, K.R., V. Veerisetty, F. Zhu, A. Razzaque, K.D. Thompson, and C. Jones. 1992. Characterization of primay human fibroblasts transformed by human papillomavirus type 16 and herpes simplex type 2 DNA sequences. J. Gen. Virol. 73: 791-799.
8. Durst, M., A. Kleinheinz, M. Hotz, and L. Gismann. 1985. The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. Virology 66: 1515-1522.
9. Dyson, N., P.M. Howley, K. Munger, and E. Harlow. 1989. The human papillomavirus-16 E7 onco protein is able to bind to the retinoblastoma gene product. Science 243: 934-937.
10. Dyson, N., P. Guida, K. Munger, and E. Harlow. 1992. Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins. J. Virol. 66: 6893-6902.
11. Gage, J.R., C. Meyers, and F.O. Wettstein. 1990. The E7 proteins of the nononcogenic human papillomavirus type 6b (HPV-6b) and of the oncogenic HPV-16 differ in retinoblastoma protein binding and other properties. J. Virol 46: 723-730.
12. Halben, C.L., G.W. Demers, and D.A. Galloway. 1991. The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J. Virol 65: 473-478.
13. Halben, C.L., G.W. Demers, and D.A. Galloway. 1992. The E6 and E7 genes of human papillomavirus type 6 have weak immmortalizing activity in human epithelial cells. J. Virol. 66: 2125-2134.
14. Hartwell, L.H. and T.A. Weinert. 1989. Checkpoints: Controls that ensure the order of cell cycle events. Science 246: 629-633.
15. Hashida, T. and S. Yasumoto. 1991. Induction of chromosomal abnormalities in mouse and human epidermal keratinocytes by the human papillomavirus type 16 E7 oncogene. J. Gen. Virol. 72: 1569-1577.
16. Hawley-Nelson, P., K.H. Vousden, N.L. Hubbert, D.R. Lowy, and J.T. Schiller. 1989. HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J. 8: 3905-3910.
17. Jonczyk, P., A. White, K. Lum, J.C. Barrett, and T.D. Tlsty. 1993. Amplification potential in preneoplastic and neoplastic Syrian hamster embryo fibroblasts transformed by various carcinogens. Cancer Res. 53: 3098-3102.
18. Kastan, M.B., O. Onyekwere, D. Sidransky, B. Vogelstein, and R.W. Craig. 1991. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51: 6304-6311.
19. Kuerbitz, S.J., B.S. Plunkett, W.V. Walsh, and M.B. Kastan. 1992. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. 89: 7491-7495.
20. Livingstone, L.R., A. White, J. Sprouse, E. Livanos, T. Jacks, and T.D. Tlsty. 1992. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70: 923-935.
21. Ma, C., S. Martin, B. Trask, and J.L. Hamlin. 1993. Sister chromatid fusion initiates amplification of the dihydrofolate reductase gene in Chinese hamster cells. Genes & Dev. 7: 605-620.
22. McClintock, B. 1939. The behavior in sucessive nuclear divisions of a chromosome broken at meiosis. Proc. Natl. Acad. Sci. 25: 405-416.
23. _. 1942. The fusion of broken ends of chromosomes following nuclear fusion. Proc. Natl. Acad. Sci. 28: 458-463.
24. Munger, K., W.C. Phelps, V. Bubb, P.M. Howley, and R. Schlegel. 1989a. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J. Virol. 63:4417-4421.
25. Munger, K., B.A. Werness, N. Dyson, W.C. Phelps, E. Harlow, and P.M. Howley. 1989b. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J. 8: 4099-4105.
26. Otto, E., S. McCord, and T.D. Tlsty. 1989. Increased incidence of CAD gene amplification in tumorigenic rat lines as an indicator of genomic instability of neoplastic cells. J. Biol. Chem. 264: 3390-3396.
27. Pater, M.M. and A. Pater. 1985. Human papillomavirus types 16 and 18 sequences in carcinoma cell lines of the cervix. Virology 145:313-318.
28. Pecoraro, G., D. Morgan, and V. Defendi. 1989. Differential effects of human papillomavirus type 6, 16, and 18 DNAs on immortalization and transformation of human cervical epithelial cells. Proc. Natl. Acad. Sci. 86: 563-567.
29. Rao, L., M. Debbas, P. Sabbatini, D. Hockenbery, S. Korsmeyer, and E. White. 1992. The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc. Natl. Acad. Sci. 89: 7742-7746.
30. Romanczuk, H. and P.M. Howley. 1992. Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity. Proc. Natl. Acad. Sci. 89:3159-3163.
31. Sager, R., I. Gadi, L. Stephens, and C.T. Grabowy. 1985. Gene amplification: An example of accelerated evolution in tumorigenic cells. Proc. Natl. Acad. Sci. 82: 7015-7019.
32. Schaefer, D.I., E.M. Livanos, A.E.White, and T.D. Tlsty. 1993. Multiple mechanisms of N-(phosphonoacetyl)-L-aspartate drug resistance in SV40-infected precrisis human fibroblasts. Cancer Res. 53:4946-4951.
33. Scheffner, M., B.A. Werness, J.M. Huibregtse, A.J. Levine, and P.M. Howley. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129-1136.
34. Schlegel, R., W.C. Phelps, Y.L. Zhang, and M. Barbosa. 1988. Quantitative keratinocyte assay detects two biological activities of human papillomavirus DNA and identifies viral types associated with cervical carcinoma. EMBO J. 7: 3181-3187.
35. Schwarz, E., U.K. Freese, L. Gissman, W. Mayer, B. Roggenbuck, A. Stremlau, and H. zur Hausen. 1985. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314: 111-114.
36. Shay, J.W., W.E. Wright, D. Brasiskyte, and B.A. Van Der Haegen. 1993. E6 of human papillomavirus type 16 can overcome the M1 stage of immortalization in human mammary cells but not in human fibroblasts. Oncogene 8: 1407-1413.
37. Smith, K.A., P.A. Gorman, M.B. Stark, R.P. Groves, and G.R. Stark. 1990. Distinctive chromosomal structures are formed very early in the amplification of CAD genes in Syrian hamster cells. Cell 63: 1219-1227.
38. Smotkin, D. and P.O. Wettstein. 1986. Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein. Proc. Natl. Acad. Sci. 83: 4680-4684.
39. Tlsty, T.D. 1990. Normal diploid human and rodent cells lack a detectable frequency of gene amplification. Proc. Natl. Acad. Sci. 87:3132-3136.
40. Tlsty, T.D., B. Margolin, and K. Lum. 1989. Differences in the rates of gene amplification in nontumorigenic and tumorigenic cell lines as measured by Luria-Delbruck fluctuation analysis. Proc. Natl. Acad. Sci. 86: 9441-9445.
41. Tlsty, T.D., A. White, and J. Sanchez. 1992. Suppression of gene amplification in human cell hybrids. Science 255: 1425-1427.
42. Toledo, F., D. Le Roscouet, G. Buttin, ad M. Debatisse. 1992. Co-amplified markers alternate in megabase long chromosomal inverted repeats and cluster independently in interphase nuclei at early steps of mammalian gene amplification. EMBO J. 11: 2665-2673.
43. Tommasino, M., J.P. Adamczewski, F. Carlotti, C.F. Barth, R. Manetti, M. Contorni, F. Cavalieri, T. Hunt, and L. Crawtord. 1993. HPV16 E7 protein associates with the protein kinase p33CDK2 and cyclin A. Oncogene 8: 195-202.
44. Trask, B. and J. Hamlin. 1989. Early dihydrofolate reductase gene amplification events in CHO cells usually occur on the same chromosome arm as the original locus. Genes &. Dev. 3: 913-1920.
45. Vousden, K.H. and P.S. Jat. 1989. Functional similarity between HPV16 E7, SV40 large T and adenovirus E1a proteins. Oncogene 4: 153-158.
46. Watanabe, S., T. Kanda, and K. Yoshiike. 1989. Human papillonuvirus type 16 transformantion of primary human embryonic fibroblasts requires expression of open reading frames E6 and E7. J. Virol. 63: 965-969.
47. Werness, B.A., A.J. Levine, and P.M. Howley. 1990. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248: 76-79.
48. Wilczynski, S.P., L. Pearlman, and J. Walker. 1988. Identification of HPV early genes retained in cervical carcinomas. Virology 166: 624-627.
49. Windle, B., B.W. Draper, Y. Yin, S. O'Gorman, and G.M. Wahl. 1991. A central role for chromosome breakage in gene amplification, deletion formation, and amplicon integration. Genes & Dev. 5:160-174.
50. Wright, J.A., H.S. Smith, F.M. Watt, M.C. Hancock, D.L. Hudson, and G.R. Stark. 1990. DNA amplification is rare in normal human cells. Proc. Natl. Acad. Sci. 87: 1791-1795.
51. Yin, Y., M.A. Tainsky, F.Z. Bischoff, L.C. Strong, and G.M. Wahl. 1992. Wild type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70: 937-948.
52. Yonish-Rouach, E., D. Grinwald, S. Wilder, A. Kimchi, E. May, J. Lawrence, P. May, and M. Oren. 1993. p53-mediated cell death: Relationship to cell cycle control. Mol. Cell. Biol. 13: 1415-1423.
53. zur Hausen, H. 1991. Human papillomaviruses in the pathogenesis of anogential cancer. Virology 184: 9-13..